Spirix

Quick links to important sections

Medically reviewed

Laura Arias

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Spirix

What is Spirix: Active Ingredient and Classification

Property Description
Active ingredient Spironolactone (INN)
Form Tablet (Oral administration)
Pharmacological class Mineralocorticoid Receptor Antagonist (ARA), Potassium-Sparing Diuretic
General purpose Fluid volume and electrolyte regulation
Origin Synthetic steroid lactone

Spirix is a trade name for a prescription-only medicine containing the active ingredient Spironolactone (INN), a compound that is chemically defined as a synthetic steroid lactone. This core classification establishes Spirix as a Potassium-Sparing Diuretic, a type of medicine that assists the body in managing fluid levels. Pharmacologically, it functions primarily as a Mineralocorticoid Receptor Antagonist (ARA) by blocking the effects of the hormone aldosterone.

The unique profile of Spironolactone is recognized for its nonselective action, which extends beyond the mineralocorticoid receptors. This distinguishing feature means that the drug also engages androgen and progesterone receptors, providing it with supplementary anti-androgenic effects that are beneficial in specific therapeutic contexts. This dual hormonal and diuretic capability differentiates it within its class.


Forms and Defining the Action of Spironolactone

Spirix is designed as a single-ingredient product intended for oral administration, typically manufactured as a tablet. The fundamental physiological action of Spironolactone is the competitive binding to the aldosterone receptor in the kidneys. By acting as an antagonist, the drug prevents aldosterone from signaling the body to retain sodium and excrete potassium.

This action directly promotes natriuresis (sodium excretion) and subsequent diuresis (water excretion) while crucially promoting potassium retention. This specific mechanism helps prevent the risk of hypokalemia, a concern with other types of fluid-regulating medicines. This confirms that the medicine helps the body shed excess fluid without causing critical potassium loss.


The General Purpose of a Potassium-Sparing Diuretic

The general therapeutic purpose of Spirix is the regulation of fluid volume and the maintenance of electrolyte balance throughout the body. Its potassium-sparing nature provides a key advantage in managing conditions where excess fluid needs to be removed while preserving essential mineral balance.

The drug plays a role in promoting cardiovascular health through its ability to manage fluid balance effectively. The additional anti-androgenic effects arising from the drug’s receptor binding extend its general utility, for instance, in female patients requiring hormonal moderation alongside fluid regulation.

What side effects are possible with Spirix?

Possible Side Effects and Safety Information

The safety profile of Spirix (Spironolactone) is officially documented by frequency and the physiological system affected, reflecting the medicine's primary action on mineralocorticoid receptors and its secondary effects on androgen and progesterone receptors.

Official Adverse Reaction Classification

Classification Examples of Reactions (Regulatory Terminology)
Very Common Hyperkalemia (high potassium levels).
Common Gynaecomastia (male breast enlargement), headache, gastrointestinal disorders (e.g., diarrhea), and menstrual irregularities.
Uncommon Nausea, vomiting, mental confusion, and hypersensitivity reactions.
Rare Severe blood disorders (e.g., agranulocytosis), gastrointestinal ulceration/bleeding, and liver dysfunction.
Not Known Severe cutaneous adverse reactions (SCARs), including Stevens-Johnson syndrome (SJS) and Toxic Epidermal Necrolysis (TEN).

Serious Adverse Reactions and Population Constraints

The most significant and commonly cited safety concern is the risk of Severe Hyperkalemia, which is classified in regulatory documents as potentially life-threatening. Other serious reactions explicitly listed include Acute Kidney Injury/Failure and Gastrointestinal Hemorrhage.

Safety notes for specific populations are detailed in official labeling. The medicine is contraindicated in patients with pre-existing hyperkalemia, anuria, or acute renal impairment. Furthermore, caution is advised for older adults due to an officially documented increased risk of hyperkalemia and renal effects. Regulatory text also notes that certain effects, such as gynaecomastia, are explicitly related to both the administered dose and the duration of continuous treatment.

Overdose and Emergency Response

Overdose and when to seek help

Overdose of Spirix (Spironolactone) is primarily characterized by severe electrolyte imbalance, most significantly hyperkalemia (high potassium) and subsequent hyponatremia (low sodium). Manifestations documented in official regulatory labeling include central nervous system disturbances such as drowsiness, mental confusion, and dizziness, along with gastrointestinal effects like nausea, vomiting, and diarrhea. Neuromuscular signs such as weakness and paresthesia are also listed.

The most critical consequence is the potential for life-threatening cardiac dysrhythmias (irregular heartbeat) which can be fatal. This risk is explicitly heightened in patients with underlying impaired renal function or severe heart failure, requiring enhanced awareness.

Immediate medical attention is required whenever an overdose is suspected or if severe, life-threatening symptoms occur. Regulatory guidance advises contacting emergency services immediately.

Official management procedures are defined as symptomatic and supportive treatment. Regulators state that no specific antidote is known for Spironolactone overdose. Treatment focuses on correcting the electrolyte imbalance, including continuous monitoring of serum electrolytes and necessary procedural interventions to reduce potassium levels.

Therapeutic Uses of Spirix

What Spirix Treats: Main Uses and Benefits

Spirix is commonly used for managing conditions characterized by excess fluid retention, such as conditions marked by increased physiological stress, including chronic heart and liver conditions. It is applied across domains where additional symptomatic support is needed to address symptoms that create noticeable physiological strain, like edema (swelling) and ascites (abdominal fluid buildup). This medicine is used as a component for treating fluid retention and high blood pressure. This medication may assist with maintaining functional stability by supporting the easing of the overall symptom burden of volume overload.


The drug is commonly used to help manage the symptoms of hyperaldosteronism and resistant hypertension. Furthermore, it is applied in specialized contexts, and may assist female patients with managing symptoms related to hormonal excess, such as hirsutism and adult acne vulgaris. A key therapeutic advantage is its role in supporting mineral balance, which may help reduce the risk of muscle weakness and fatigue associated with low potassium, while contributing to the management of blood pressure.

The primary benefit is offering supportive relief that helps patients cope more steadily with symptom fluctuations arising from fluid and hormonal imbalances.


Supportive Management

It is considered relevant in contexts involving heightened systemic burden and may offer supportive relief during difficult symptomatic phases. This use may contribute to easing the overall symptom load and assist patients with maintaining a sense of stability when symptoms are more noticeable.


Quick Fact: Supportive management for Fluid Retention Spirix is commonly used to help address pronounced swelling and fluid buildup associated with severe chronic conditions, and its use is considered relevant when supportive symptom management is appropriate.

Regulatory References

  1. NIH MedlinePlus overview on Spironolactone

Eligibility and Restrictions for Use

Who can and cannot use SPRIX? — Official Regulatory Information

SPRIX is an Nonsteroidal Anti-inflammatory Drug (NSAID) indicated only for adult patients for the short-term (maximum of 5 days total) management of moderate to moderately severe acute pain. Use is strictly limited to five days and it is not for use in pediatric patients.

Populations for Whom Use is Prohibited (Contraindicated)

This medicine must not be used by patients with:

  • A known allergy or hypersensitivity to ketorolac, aspirin, or any other NSAIDs.
  • Active peptic ulcer disease or a recent history of gastrointestinal bleeding or perforation.
  • A history of or current cerebrovascular bleeding, hemorrhagic diathesis, or other conditions where hemostasis is critical.
  • Advanced renal disease or patients at risk for kidney failure due to volume depletion.
  • Use just before or after coronary artery bypass graft (CABG) surgery.
  • Labor and delivery.
  • Concomitant use with probenecid or pentoxifylline.

Special Considerations and Avoidance

Use should be avoided in pregnant women from 30 weeks gestation onward. Physicians should use caution when prescribing for patients with severe heart failure or a prior history of ulcer disease or GI bleeding. The total duration of treatment with any formulation of ketorolac (nasal, oral, or injection) must not exceed 5 days.

What should I know about interactions with other medicines?

Interactions with other medicines and products

The following section summarizes the officially documented information regarding interactions between Spironolactone (often marketed as Spirix/Aldactone) and other substances, as detailed in authoritative regulatory labeling from government health agencies.

Potential for Increased Potassium Levels (Hyperkalaemia)

Co-administration of Spironolactone with specific medicines or products may significantly increase serum potassium, potentially leading to hyperkalaemia. This interaction is primarily pharmacodynamic.

Interacting Product Category Example Substances Interaction Statement
Potassium-Related Agents Potassium supplements, other potassium-sparing diuretics (e.g., eplerenone) Use is restricted due to high risk of severe hyperkalaemia.
Cardiovascular Agents Angiotensin-Converting Enzyme (ACE) inhibitors, Angiotensin Receptor Blockers (ARBs), Heparin Concomitant use increases the risk of hyperkalaemia, requiring close monitoring of potassium and renal function.
Antibiotics/NSAIDS Trimethoprim/sulfamethoxazole (Co-trimoxazole), Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Increased risk of hyperkalaemia. NSAIDs may also attenuate the diuretic effect.

Other Clinically Relevant Interactions

Interactions not solely related to potassium management are also officially documented:

  • Digoxin: Spironolactone may increase serum Digoxin concentrations and half-life, necessitating careful monitoring when both are administered.
  • Antihypertensives: Co-administration with other antihypertensive agents, including ganglion-blocking drugs, may lead to an enhanced blood pressure-lowering effect.
  • Food: Regulatory labeling indicates that Spironolactone should be taken with food to increase the systemic exposure of the unchanged drug.
  • Abiraterone: Concomitant use is generally not recommended as Spironolactone can bind to the androgen receptor.

Mechanism of Action

How Spirix Works: Mechanism of Action

Spirix acts primarily by competitively blocking the Mineralocorticoid Receptor (MR), particularly in the renal tubules, thereby interrupting the genomic signaling of aldosterone. This molecular antagonism halts the synthesis of key transport proteins, which ultimately promotes the urinary excretion of sodium and water while supporting the retention of potassium—the resulting physiological consequence of the mechanism.

The molecule's synthetic steroidal structure grants it nonselective affinity, extending its action to the Androgen Receptor (AR) in peripheral tissues. This interaction interrupts natural androgen signaling, leading to a biological consequence that reduces local androgenic influence alongside its primary electrolytic function.

Furthermore, MR antagonism operates outside the kidney in the myocardium and vascular tissues. By blocking the receptor in these locations, the drug interferes with aldosterone-driven processes that promote pathological cellular remodeling and fibrosis. This non-diuretic effect results in the attenuation of pathological tissue remodeling independent of the fluid volume reduction.

Dosage and Administration Information

How to Use Spirix: Official Administration Guidelines

Spirix (Spironolactone) is designated exclusively for oral administration, utilizing either the available tablet strengths (25 mg, 50 mg, and 100 mg) or the oral suspension form. To ensure consistent drug absorption, the medicine is taken consistently with respect to food, meaning intake is always with a meal or always without.

The typical daily dosage is highly specific to the clinical context. Regimens range from 25 mg every other day for dose reduction in certain heart conditions to a maximum of 400 mg/day for severe volume overload. For essential hypertension, initial doses generally range between 25 mg/day and 100 mg/day. The total daily amount can be administered as a single dose or divided into multiple doses throughout the day. Dose adjustments are cautiously managed and often require a minimum of five days to two weeks before any change is implemented, allowing time to assess the full effect.

Specific rules govern administration for certain populations. The initial daily dose for pediatric patients is weight-based, typically 1 mg/kg to 3 mg/kg of body weight, administered in divided doses. For patients with reduced kidney function (e.g., eGFR 30 to 50 mL/min/1.73 m^2), starting the dose at 25 mg every other day may be required. When using the liquid form, the oral suspension must be shaken thoroughly before each measured use, and tablets may be pulverized for specific needs. This medicine is often utilized as part of a long-term maintenance regimen.

Recent Clinical Evidence

Spirix: Recent Clinical Evidence

Research on the compound in Spirix has focused on its role in cardiovascular and fluid-related conditions, particularly its function as a mineralocorticoid receptor antagonist.

A. Evidence in Chronic Heart Failure

The landmark Randomized Aldactone Evaluation Study (RALES), a placebo-controlled, double-blind trial, examined the effect of the compound on highly symptomatic heart failure patients (NYHA Class III-IV) with reduced ejection fraction. The study was stopped early due to the significant impact observed.

  • The trial reported a 30% relative reduction in the risk of all-cause mortality compared to placebo.
  • It was also associated with a 30% reduction in the risk of hospitalization for cardiac causes (including worsening heart failure, angina, ventricular arrhythmias, or myocardial infarction).

B. Studies in Resistant Hypertension and Post-Myocardial Infarction

Clinical data supports the use of the compound as an add-on therapy for patients with resistant hypertension (blood pressure that remains high despite taking multiple other medications, including a diuretic). Studies show that adding the compound to existing multidrug regimens may be associated with lowered blood pressure.

A separate trial, conducted in patients following a myocardial infarction (heart attack), investigated the use of the compound regardless of baseline heart function. While the trial did not find a significant difference in major cardiovascular event rates or death, it did report a reduced likelihood of new or worsening heart failure in the group receiving the compound compared to placebo.

C. Key Safety Findings from Trials

Long-term follow-up in the RALES study identified potential adverse events, including an increased risk of hyperkalemia (high potassium levels) and gynecomastia (breast enlargement in males) compared to placebo. These safety findings highlight the need for careful patient selection and routine monitoring of serum potassium levels, especially in individuals with pre-existing kidney conditions.

Frequently Asked Questions (FAQ)

Common questions about Spirix (FAQ)


Q: How quickly should I expect Spirix to start working?

The onset of action depends on the condition being addressed. For the initial effect of fluid removal (diuresis), some action may be seen within a few hours. However, to achieve the full therapeutic benefit for managing blood pressure or controlling fluid volume, official information indicates it may take up to two weeks.

Q: Can Spirix affect my sleep?

Official adverse reaction reports indicate that the medicine can cause central nervous system effects such as drowsiness, lethargy, mental confusion, or restlessness. These documented effects may indirectly impact sleep.

Q: Are there any foods or drinks I need to avoid while taking Spirix?

Regulatory documents indicate that it is important to minimize or avoid foods, drinks, and salt substitutes that are high in potassium. This is because Spirix is a potassium-sparing medicine, meaning it promotes potassium retention, and consuming excessive amounts can lead to high blood potassium levels (hyperkalemia).

Q: Is it normal to feel slightly dizzy when first starting Spirix?

Dizziness, lightheadedness, or fainting is noted as a possible occurrence, particularly when initiating treatment or changing body positions quickly. Official prescribing information states that this is associated with the medicine's blood pressure-lowering effect.

Q: Does Spirix have a generic version available?

The active ingredient in Spirix, spironolactone, is widely available as a generic medication. The generic version contains the active ingredient spironolactone and is subject to regulatory requirements designed to ensure equivalence to the brand-name product.

Q: How long does Spirix stay in your system after stopping treatment?

While the active ingredient itself is quickly processed, its active chemical byproducts (metabolites) remain in the body longer. Regulatory documents on pharmacokinetics indicate that these metabolites can stay in the system for several days to a week after the last dose.

Q: Can older adults safely take Spirix?

Official guidelines indicate that caution is advised when the medicine is used in older adults. Due to an increased risk of elevated potassium levels (hyperkalemia) and effects on kidney function, close monitoring of kidney function and electrolytes is necessary for this population.

Q: Do I need a special diet while taking Spirix?

The primary consideration is restricting high-potassium foods and supplements. Official instructions also recommend taking the medicine consistently with food to enhance the body's absorption.

Q: Is there a risk of dependence or addiction with Spirix?

The medicine is not classified as a controlled substance. Official drug documents do not list dependence or addiction as a potential risk.

Q: What should I do if I miss a dose of Spirix?

If a dose is missed, take it as soon as it is remembered, unless it is close to the time of the next scheduled dose (e.g., late in the day). Patients are advised not to take two doses at once to make up for the one that was missed.

Q: Can I take Spirix if I have a history of [common chronic condition]?

Official information indicates the medicine is contraindicated (use is generally not recommended or advised against) in patients with acute kidney failure, anuria (inability to pass urine), Addison's disease, or pre-existing high potassium levels. Other chronic conditions may require specific monitoring.

Q: Is Spirix known to cause weight gain or loss?

The medicine's diuretic effect works by helping the body shed excess fluid and sodium, which may result in a temporary weight loss. Weight gain is not listed as a direct side effect in official prescribing information.

Q: What happens if Spirix is stopped suddenly?

Official patient information indicates that stopping the medicine abruptly may cause the underlying condition it is treating (such as heart failure or high blood pressure) to worsen. Official guidance indicates that dose adjustments or discontinuation should be managed by a healthcare professional.

Q: Does Spirix interact with birth control pills?

Official guidance warns that Spirix can interact with birth control pills that contain the progestin drospirenone, which can lead to a heightened risk of high potassium levels (hyperkalemia). Patients are advised to share all medications with their prescribing physician.

Q: Can Spirix change the color of my urine?

While the medicine itself is not known to change urine color, it is a diuretic. Symptoms of potential dehydration caused by fluid loss, such as dark yellow or brown urine, are a possibility that should be noted.

Q: Does taking Spirix cause fatigue?

Yes, official adverse reaction information lists fatigue, drowsiness, and lethargy as potential side effects associated with this medicine.

Q: Is there a specific time of day that Spirix is usually taken?

It is typically recommended to take a single daily dose in the morning. If the total dose is divided, regulatory patient information suggests the second dose should be taken by the late afternoon to help prevent night-time urination.

Q: Does Spirix interact with alcohol?

Official labeling notes that alcohol consumption may potentiate (enhance) the medicine's blood pressure-lowering effect. This can lead to an increased risk of dizziness, lightheadedness, or fainting.

Q: Is Spirix effective for all stages of the treated condition?

Official prescribing information and clinical studies often specify the medicine's use for severe or advanced cases, such as New York Heart Association (NYHA) Class III-IV heart failure or resistant hypertension. The suitability may depend on the specific stage being managed.

Q: What should I do if I get pregnant while taking Spirix?

Due to its anti-androgenic (anti-male hormone) properties, official regulatory documents advise generally avoiding this medicine during pregnancy due to the potential risk of adverse effects to a male fetus. Regulatory documents indicate that a patient who becomes pregnant should be informed of the potential hazards.

Q: Does Spirix interact with herbal supplements like St. John's Wort?

Official guidance recommends that patients inform their healthcare professional about all herbal remedies and supplements. Supplements, especially those containing high levels of potassium, must be used with caution, as they can cause a severe increase in blood potassium when combined with this medicine.

Q: Is it safe to drive or operate machinery while on Spirix?

Caution is advised when operating machinery or driving a vehicle. Regulatory information states that the medicine may cause dizziness or drowsiness, and patients should wait until they know how the medicine affects them before engaging in these activities.

Q: Can Spirix make me more sensitive to the sun?

Yes, official prescribing information has reported photosensitivity (an increased sensitivity to the sun) as a possible adverse reaction. Protective measures against sun exposure may be recommended.

Q: Is Spirix suitable for people with kidney issues?

The medicine is contraindicated (use is generally not recommended or advised against) for patients with severe acute kidney problems. For patients with certain levels of reduced kidney function, the dose may need to be adjusted, and kidney function requires close and routine monitoring.

Q: Can taking Spirix affect the results of a drug test?

Spirix's active ingredient, spironolactone, is classified as a prohibited diuretic and masking agent by international athletic organizations. This classification means it has the potential to affect the results of a urine drug test.

Q: Is it possible to be allergic to Spirix?

Yes, the official prescribing information lists hypersensitivity reactions as a possible adverse effect and specifically contraindicates the drug for patients with a known allergy to spironolactone. Signs of an allergic reaction include rash, hives, and swelling of the face, lips, or throat.

Q: What is the expected timeline for feeling the full effects of Spirix?

The timeline varies based on the effect being monitored. The full effect for fluid management or blood pressure may take up to two weeks. If being used for anti-androgen effects, official information indicates the full effect may take 2 to 5 months.

Q: What are the most common reasons a doctor prescribes Spirix?

According to official indications, common reasons include managing chronic heart failure, treating resistant hypertension (high blood pressure not controlled by other medicines), and addressing fluid retention (edema) due to cirrhosis or nephrotic syndrome.

Q: Can I take Spirix if I have a gluten intolerance?

The full prescribing information includes a complete list of inactive ingredients, or excipients. Reviewing this list with a pharmacist or healthcare provider is generally recommended for patients with a severe intolerance, as official documents do not typically provide a definitive 'gluten-free' certification.

Q: What are the ingredients in Spirix besides the active one?

The full regulatory prescribing information (such as the FDA label or SmPC) provides a complete, itemized list of all inactive ingredients (excipients) used in the product formulation alongside the active ingredient, spironolactone.

Q: Does Spirix cause dry mouth?

While dry mouth is not explicitly listed as a common side effect, the medicine is a diuretic. The official label notes symptoms of potential dehydration (thirst), and dry mouth can be a related symptom of fluid loss.

Q: Is Spirix suitable for vegetarians or vegans?

Official drug documents list all inactive ingredients, which can be reviewed to determine suitability. However, the regulatory documentation itself does not contain a formal certification regarding the product's suitability for vegetarian or vegan diets.

How should Spirix be stored and disposed of?

Official Storage and Disposal Requirements

Regulatory documentation specifies strict conditions for the storage and disposal of Spirix to maintain its safety and effectiveness.

Storage Domain Required Conditions
Temperature Store at controlled room temperature (20 C to 25 C).
Protection Keep in the original, tightly closed container, protected from excess heat and moisture. Do not refrigerate or freeze unless otherwise instructed by the label.
Safety The product must be stored out of the reach of children (up and away).

For disposal, unused or expired Spirix should be taken to a drug take-back location. If this is not possible, the medicine must be disposed of via the official household trash method, which involves mixing the drug with an undesirable substance, sealing it in a container, and avoiding environmental contamination by not flushing it down the toilet.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Spirix found in:

A-Z Index: